Sunao Manabe
Chief Executive Officer at DAIICHI SANKYO CO., LTD.
Sunao Manabe active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DAIICHI SANKYO CO., LTD. | Chief Executive Officer | 01/06/2019 | - |
| Chairman | - | - | |
| Director/Board Member | 01/06/2014 | - | |
| Chief Operating Officer | 01/04/2017 | 01/06/2019 | |
| Human Resources Officer | 01/06/2016 | 01/04/2017 | |
| Corporate Officer/Principal | 01/04/2007 | 01/06/2016 | |
| President | 01/04/2017 | - | |
| Sales & Marketing | 01/04/2015 | 01/04/2016 | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | 12/07/2023 | - |
Career history of Sunao Manabe
Statistics
International
| Japan | 2 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
- Stock Market
- Insiders
- Sunao Manabe
- Experience
